Patent · US Active

2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronapthalen-1(2H)-one

US7358269B2 · kind B2 · utility

3Cited by
13References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 6, 2006
Grant dateApr 15, 2008
Priority date—
Expiry dateAug 10, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D409/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound of the formulaor a pharmaceutically acceptable salt thereof, is disclosed herein. Methods and compositions related thereto are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.